Document is current
Any future updates will be listed below
-
Authors
Stapper, Noah https://orcid.org/0000-0002-1674-6718
Benster, Lindsay L. https://orcid.org/0000-0003-0510-6448
Menon, Sahit
Boyd, Emma C.
Poorganji, Mohsen
Hadas, Itay https://orcid.org/0000-0001-7518-1182
Sun, Yinming
Appelbaum, Lawrence G. https://orcid.org/0000-0002-3184-6725
Daskalakis, Zafiris J.
Weissman, Cory R. https://orcid.org/0000-0002-5087-8263
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23MH138746)
- License Information
-
More Information
Article History
Received: 17 June 2024
Revised: 20 June 2025
Accepted: 11 July 2025
First Online: 17 November 2025
Competing interests
: Dr Daskalakis has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc and industry-initiated trials through Magnus Inc and currently serves on the scientific advisory board for Brainsway Inc. Dr Weissman has served as a consultant for Goodcap Pharmaceuticals Inc.
